+0.27%
Today
Loading 1D prices…
Company profile
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Sector
Health Care
Industry
Medicinal Chemicals & Botanical Products
Exchange
Nasdaq
Display currency
USD
Location
Causeway Bay, United States
Employees
10
CIK
1829667
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| TRLVTrulieve Cannabis Corp. Subordinate Voting Shares | $2.2B | $1.2B | -9.85% | -$0.58 | +0.00% | Buy |
| DFTXDefinium Therapeutics Inc. Common Shares | $5.2B | $0.00 | — | -$2.06 | +3.13% | Buy |
| CRONCronos Group Inc. Common Share | $1.2B | $146.6M | -1.98% | -$0.02 | -0.63% | Buy |
| GLASGlass House Brands Inc. Subordinate Voting Shares | $747.3M | $182M | -16.30% | -$0.55 | -0.63% | Buy |
| TLRYTilray Brands Inc. Common Stock | $553.1M | $915.5M | -13.26% | -$1.09 | -3.02% | Hold |